Target intelligence / Profile preview

Mitochondrial inner membrane oxidative phosphorylation system

Molecular classification
Other (membrane structure and multi-protein complexes)
01

Overview

The **mitochondrial inner membrane oxidative phosphorylation system** (OXPHOS) refers to the ensemble of protein complexes embedded in the inner mitochondrial membrane that carry out electron transport and ATP synthesis, the final step of cellular respiration[3][4][5][6][7]. The inner membrane houses the electron transport chain (ETC) complexes I-IV (NADH dehydrogenase, succinate dehydrogenase, ubiquinol-cytochrome c oxidoreductase, cytochrome c oxidase) and ATP synthase (complex V), collectively catalyzing the transfer of electrons from reduced substrates (NADH, FADH2) to oxygen, coupled to the active transport of protons to generate an electrochemical gradient (proton motive force)[1][3][4][5][6]. ATP synthase uses this gradient to drive phosphorylation of ADP to ATP, supplying energy essential for nearly all cellular processes. Defects in this system are implicated in a wide spectrum of human diseases, especially those affecting organs with high metabolic requirements such as the brain and heart[3][5]. Note: "Mitochondrial inner membrane / oxidative phosphorylation" is not a single molecular target but a structural system and process composed of multiple distinct protein complexes; for drug development or biological targeting, one typically refers to individual complexes (e.g., NADH dehydrogenase, cytochrome c oxidase) rather than the entire membrane or process collectively[1][3][4].

Other names
inner mitochondrial membraneIMMoxidative phosphorylation systemelectron transport chainOXPHOS
02

Mechanism of action

Inhibition of specific electron transport chain complexes (I-IV) - Uncoupling of ATP synthesis from electron transport - Modulation of proton gradient or membrane potential

03

Biological functions

ATP synthesisElectron transportCellular respirationGeneration of membrane potentialMetabolism
04

Disease associations

Neurodegenerative diseaseCardiovascular diseaseMetabolic disordersMitochondrial diseasesAging-related disorders
05

Safety considerations

Mitochondrial toxicityLactic acidosisImpaired ATP productionOxidative stress
06

Interacting drugs

Metformin

5 more in the full profile.

07

Biomarkers

Lactate levelsNADH/NAD+ ratioATP/ADP ratioCytochrome c releaseMitochondrial membrane potential (Δψm)

Beyond the preview

Go deeper on Mitochondrial inner membrane oxidative phosphorylation system.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial inner membrane oxidative phosphorylation system.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call